SCHEMBL5954905

SCHEMBL5954905

CCOC(=O)C1CCN(c2ccccn2)CC1C(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.45
DPP4 P27487 1/20 0.43
DPP8 Q6V1X1 1/20 0.43
DPP9 Q86TI2 1/20 0.43
DPP7 Q9UHL4 1/20 0.43
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
MAPT P10636 3/20 0.43
MAPK1 P28482 2/20 0.43
HTT P42858 2/20 0.43
ATM Q13315 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GRM1 Q13255 3/20 0.42
NOS2 P35228 1/20 0.42
HRH3 Q9Y5N1 1/20 0.41
P2RX7 Q99572 1/20 0.41
FFAR1 O14842 1/20 0.40
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2490913 0.84 DPP4 (0.47) GPR119DPP4DPP8DPP9DPP7
SCHEMBL4233275 0.83 ALDH1A1 (0.44) GPR119ALDH1A1KDM4EMAPTMAPK1
SCHEMBL896038 0.83 DPP4 (0.51) GPR119DPP4DPP8DPP9DPP7
SCHEMBL3352709 0.79 MAPT (0.57) GPR119ALDH1A1KDM4EMAPTMAPK1
SCHEMBL26255120 0.77 ALDH1A1 (0.47) GPR119ALDH1A1KDM4EMAPTMAPK1
SCHEMBL3310715 0.74 MALT1 (0.46) ALDH1A1KDM4EMAPTMAPK1HTT
SCHEMBL14709651 0.74 SMN1; SMN2 (0.45) ALDH1A1KDM4EMAPTMAPK1HTT
SCHEMBL27775216 0.73 CYP2C19 (0.50) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL16803444 0.73 SMN1; SMN2 (0.61) KDM4EHRH3LMNAKMT2A
SCHEMBL12813874 0.72 ALDH1A1 (0.55) GPR119ALDH1A1KDM4EMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060128755-A1 Amide derivative AJINOMOTO CO. INC (JP) 2006-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128755-A1 Amide derivative NR0B1, NR0B2, NR1I3 GPR119 361/4885DPP4 4297/4885DPP8 2981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.